cover image - Study Guide for Introduction to Clinical Pharmacology - Elsevier E-Book on VitalSource, 12th Edition
ISBN: 9780443411687
Copyright: 2028
Page Count: 208
Imprint: Elsevier
List Price: $42.99

Study Guide for Introduction to Clinical Pharmacology - Elsevier E-Book on VitalSource, 12th Edition

by Constance G. Visovsky, PhD, RN, ACNP-BC, FAAN, Cheryl H. Zambroski, PhD, RN and Shirley M. Hosler, MSN, RN

Elsevier eBook on VitalSource

cover image - Study Guide for Introduction to Clinical Pharmacology - Elsevier E-Book on VitalSource, 12th Edition
ISBN: 9780443411687
Copyright: 2028
Page Count: 208
Imprint: Elsevier
List Price: $42.99

$42.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 04-01-2027
Reinforce your understanding of nursing pharmacology with this practical study guide! Corresponding chapter by chapter to Introduction to Clinical Pharmacology, this workbook provides the practice and review needed to help you master pharmacology knowledge and prepare for the NCLEX-PN® Examination. A variety of exercises includes practice quizzes and case studies that emphasize clinical decision-making and prioritization. It’s the ideal study tool and review companion for your textbook! Answer keys are available to students on the accompanying Evolve website.
    • NEW! Review questions for the textbook’s two new chapters are added: Drugs for Weight Loss and Drugs for Complementary and Integrative Therapies
    • NEW! Updated exercises cover newly approved pharmaceutical treatments and drugs
    • Variety of exercises reinforces your understanding with matching, multiple-choice, fill-in-the-blank, true or false, and select-all-that-apply questions, as well as crossword puzzles
    • Alternate item format review questions prepare you for the Next Generation NCLEX® (NGN) exam
    • Practice quizzes provide preparation for course and licensure exams
    • Reader-friendly writing style and organization make the content easier to understand
  • 1. Pharmacology and the Nursing Process in LPN Practice
    2. Legal, Regulatory, and Ethical Aspects of Drug Administration
    3. Principles of Pharmacology
    4. Drug Calculation: Preparing and Administering Drugs
    5. Drugs for Inflammation and Pain
    6. Drugs for End-of-Life Care
    7. Drugs for Osteoporosis, Arthritis, and Gout
    8. Drugs for Anesthesia
    9. Drugs for Allergy and Respiratory Problems
    10. Drugs for Bacterial Infections
    11. Drugs for Tuberculosis, Fungal, and Parasitic Infections
    12. Drugs for Viral and Retroviral Infections
    13. Drug Therapy for Diabetes
    14. Drugs for Thyroid and Adrenal Problems
    15. Drugs Affecting the Renal/Urinary Systems
    16. Drugs Affecting the Cardiovascular System
    17. Drugs Affecting the Hematologic System
    18. Drugs for Gastrointestinal Problems
    19. Drugs for Cancer Treatment
    20. Drugs for Central Nervous System Problems
    21. Drugs for Mental Health
    22. Drugs for Immunization and Immunomodulation
    23. Drugs for Reproductive Health
    24. Drugs for Eye and Ear Problems
    25. Over-the-Counter Drug Therapy
    26. Complementary and Integrative Therapies
    27. Drugs for Weight Loss
  • Constance G. Visovsky, PhD, RN, ACNP-BC, FAAN, Professor and Lewis and Leona Hughes Endowed Chair in Nursing Science, College of Nursing, University of South Florida, Tampa, Florida, USA, Cheryl H. Zambroski, PhD, RN, Associate Professor, College of Nursing, University of South Florida, Tampa, Florida, USA and Shirley M. Hosler, MSN, RN, Formerly, Nursing Instructor, School of Nursing, National American University, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
    • Conformance
      • The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
      • For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
      • For queries regarding accessibility information, contact [email protected]
      • The publication was certified on 07-04-2026
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

$42.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 04-01-2027